Impact of 3‐year lifestyle intervention on postprandial glucose metabolism: the SLIM study
- 1 May 2008
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 25 (5) , 597-605
Abstract
Objective To determine the effect of a 3‐year diet and exercise lifestyle intervention, based on general public health recommendations, on glucose tolerance, insulin resistance and metabolic cardiovascular risk factors in Dutch subjects with impaired glucose tolerance (IGT).Methods The study was a randomized controlled lifestyle intervention over 3 years. A total of 147 IGT subjects (75 male, 72 female) were randomized to the intervention (INT) group or control (CON) group; 106 subjects (52 INT, 54 CON) completed 3 years of intervention. Annually, glucose, insulin and free fatty acid (FFA) concentrations were determined fasting and after an oral glucose tolerance test. Measurements of body weight, serum lipids, blood pressure and maximal aerobic capacity were also performed.Results Analysis of those who completed the 3‐year trial, showed that the lifestyle intervention improved body weight (INT −1.08 ± 4.30 kg; CON +0.16 ± 4.91 kg, P = 0.01), homeostatis model assessment index for insulin resistance and 2‐h FFA. Two‐hour glucose concentrations improved in the INT group, the difference being most pronounced after 1 year, with a return to baseline values after 3 years, from 8.59 ± 1.55 to 8.55 ± 0.34 mm; in contrast, 2‐h glucose deteriorated in the CON group—from 8.46 ± 1.84 to 9.35 ± 2.50 mm (P = 0.02). In the INT group, diabetes incidence was reduced by 58% (P = 0.025).Conclusion Our lifestyle intervention showed a sustained beneficial effect on 2‐h glucose concentrations, insulin resistance and 2‐h FFA, even after 3 years. Our lifestyle intervention is effective, but for implementation more information is needed about factors influencing adherence.Keywords
This publication has 31 references indexed in Scilit:
- Pathogenesis of Pre-DiabetesDiabetes, 2006
- Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trialThe Lancet, 2006
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006
- Impaired glucose tolerance and impaired fasting glucose — a review of diagnosis, clinical implications and managementDiabetes & Vascular Disease Research, 2005
- Postprandial dysmetabolism and cardiovascular disease in type 2 diabetesPostgraduate Medical Journal, 2005
- Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States AdultsCirculation, 2004
- Is the Current Definition for Diabetes Relevant to Mortality Risk From All Causes and Cardiovascular and Noncardiovascular Diseases?Diabetes Care, 2003
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Subclinical States of Glucose Intolerance and Risk of Death in the U.S.Diabetes Care, 2001